The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in Cardiomyocytes

Abstract : Aldosterone binds to the mineralocorticoid receptor (MR) and exerts pleiotropic effects beyond enhancing renal sodium reabsorption. Excessive mineralocorticoid signaling is deleterious during the evolution of cardiac failure, as evidenced by the benefits provided by adding MR antagonists (MRA) to standard care in humans. In animal models of cardiovascular diseases, MRA reduce cardiac fibrosis. Interestingly diuretics such as torasemide also appear efficient to improve cardiovascular morbidity and mortality, through several mechanisms. Among them, it has been suggested that torasemide could block aldosterone binding to the MR. To evaluate whether torasemide acts as a MRA in cardiomyocytes, we compared its effects with a classic MRA such as spironolactone. We monitored ligand-induced nuclear translocation of MR-GFP and MR transactivation activity in the cardiac-like cell line H9C2 using a reporter gene assay and known endogenous aldosterone-regulated cardiac genes. Torasemide did not modify MR nuclear translocation. Aldosterone-induced MR transactivation activity was reduced by the MRA spironolactone, not by torasemide. Spironolactone blocked the induction by aldosterone of endogenous MR-responsive genes (Sgk-1, PAI-1, Orosomucoid-1, Rgs-2, Serpina-3, Tenascin-X), while torasemide was ineffective. These results show that torasemide is not an MR antagonist; its association with MRA in heart failure may however be beneficial, through actions on complementary pathways.
Type de document :
Article dans une revue
PLoS ONE, Public Library of Science, 2013, 8 (9), pp.e73737. 〈10.1371/journal.pone.0073737〉
Liste complète des métadonnées

Littérature citée [43 références]  Voir  Masquer  Télécharger

https://hal.sorbonne-universite.fr/hal-01620249
Contributeur : Gestionnaire Hal-Upmc <>
Soumis le : vendredi 20 octobre 2017 - 12:10:39
Dernière modification le : mercredi 21 mars 2018 - 18:57:52
Document(s) archivé(s) le : dimanche 21 janvier 2018 - 14:04:43

Fichier

journal.pone.0073737.pdf
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

Citation

Basile Gravez, Antoine Tarjus, Ruben Jimenez-Canino, Soumaya Moghrabi, Smail Messaoudi, et al.. The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in Cardiomyocytes. PLoS ONE, Public Library of Science, 2013, 8 (9), pp.e73737. 〈10.1371/journal.pone.0073737〉. 〈hal-01620249〉

Partager

Métriques

Consultations de la notice

131

Téléchargements de fichiers

33